programa de doctorat en biomedicina...
TRANSCRIPT
PhDday
27th NovemberOrganitzat per:
Esponsoritzat per:
Programa de Doctorat en BiomedicinaPremis patrocinats per:
Programa de Doctorat en Biomedicina
Opening words
08.50-10.30
10.30-11.30
13.00-14.00
Lunch Break & Poster Session 2
11.30-13.00
Plenary lecture: Genome-centric dissection of human diseaseXavier Estivill. Center for Genomic Regulation (CRG)
Coffee Break & Poster Session 1
14.00-15.30
Oral Communications 3: Chair session by - Montse Sánchez-Céspedes and Víctor Moreno
O-17 Cancer, warts or asymptomatic infections: clinical presentation matches codon usage preferences in human papillomaviruses. Marta Félez-Sánchez.
O-18 Identification of a microRNA signature with a prognostic value in stage II colon cancer.. Adrià Closa Mosquera.
O-19 Dietary intake and biomarkers of acrylamide exposure and risk of endometrial and ovarian cancer in the EPIC study. Mireia Obón-Santacana.
O-20 Adenoviruses BiTE at cancer: an immunotherapy approach to improve oncolytic virotherapy. Carlos Alberto Fajardo.
O-21 Physical activity (PA), cardiorespiratory fitness (CRF), nutrition and weight control in breast cancer (BC) patients and survivors. Noémie Travier.
O-22 Epigenetic profiling uncovers the suppressive role of caveolae in Ewing Sarcoma. Juan Huertas Martinez.
O-23 Generation of tumorgraft models to characterize novel tumor suppressor genes implicated in lung carcinogenesis. Carolina Pereira.
O-24 The multiple roles of carcinoma associated fibroblast-soluble factors in chemoresistance in colorectal cancer. Samuel Gonçalves Ribeiro.
15.30-17.00
17.00-17.10
Prize to the best oral communication, sponsored by the Ajuntament de l’Hospitalet and Prizes to the best posters, sponsored by the Ajuntament de l’Hospitalet and FEBS Journal
17.10-18.00
Closing act
Oral Communications 1: Chair session by - Francisco Ciruela and Miquel Pujol
O-01 Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Barcelona, Spain, 2012-2013. Mariana Adriao Camoez.
O-02 Orexin and sleep quality in anorexia nervosa: clinical relevance and influence in treatment outcome..Sarah Sauchelli Toran.
O-03 Mechanisms governing the assembly, trafficking and function of the RetGC/GCAPs protein complex responsible for cGMP synthesis in retinal photoreceptor cells. Santiago López Begines.
O-04 Impact of immunomodulatory treatment on disability progression in relapsing remitting multiple sclerosis. Laura Bau Vila.
O-05 Phenotypic virulence factors among hypermucoviscous Klebsiella pneumoniae isolates causing bacteraemia. Meritxell Cubero.
O-06 When learning is its own reward: intrinsic reward-related activation of dopaminergic midbrain enhances word-learning. Pablo Ripollés.
O-07 Loss of function of a regulator of energy metabolism halts axonal degeneration in x-linked adrenoleukodystrophy. Pablo Ranea Robles.
O-08 Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients. Elisabet Matas Martín.
08.30-08.50
18.00-18.10
18.10-18.20
Oral Communications 2: Chair session by - Albert Tauler and Oscar Martínez Tirado
O-09 Glucose deprivation induces apoptosis through ATF4-dependent TRAIL-R2/DR5 up-regulation. Raffaella Iurlaro.
O-10 SirT2-dependent epigenetic control of the cell cycle. Núria Sima Teruel.
O-11 Epigenetic inactivation of SLFN11 confers resistance to platinum agents in ovarian and lung cancer. Vanesa Nogales Trallero.
O-12 Lineage tracing of cardiac myocytes during zebrafish heart regeneration. Isil Tekeli.
O-13 Targeting GMP synthesis, ribosomal biogenesis and p53-cell cycle control as a therapeutic approach in colorectal cancer. Ferran Riaño-Canalias.
O-14 TBC1D16 hypomethylation: A novel epigenetic biomarker for melanoma. Miguel Vizoso Patiño.
O-15 Role of p110α/PI3K in the sprouting angiogenic process and its mechanism of action. Ana Angulo Urarte.
Break
Round table: Job opportunities after PhDChair session by Jaume Reventós. Institut d'Investigació Biomèdica de Bellvitge.
• Carles Soriano Mas. Miguel Servet Researcher, Psychiatry and Mental Health Group, IDIBELL.
• Cristina Muñoz Pinedo. Group leader, Cell Death Regulation Group, IDIBELL.• Isabel María Ramis Juan. Scientific Office Manager, CIBERDEM.• Manel Cascalló Piqueras. CEO at VCN Biosciences.• Nadia El-M jiyad. Scientific Officer at European Research Council (ERC).
O-16 c-Myc and ribosome biogenesis: Role of the RPL5/RPL11/5S rRNA-Hdm2 inhibitory complex in stabilizing p53. Carmen Morcelle Magaña.